Australia markets closed
  • ALL ORDS

    7,266.30
    +151.80 (+2.13%)
     
  • ASX 200

    6,988.10
    +149.80 (+2.19%)
     
  • AUD/USD

    0.6991
    -0.0042 (-0.60%)
     
  • OIL

    87.63
    +1.02 (+1.18%)
     
  • GOLD

    1,784.10
    -10.90 (-0.61%)
     
  • BTC-AUD

    52,976.60
    +673.16 (+1.29%)
     
  • CMC Crypto 200

    843.48
    +1.03 (+0.12%)
     
  • AUD/EUR

    0.6263
    -0.0045 (-0.72%)
     
  • AUD/NZD

    1.0674
    -0.0007 (-0.06%)
     
  • NZX 50

    11,852.15
    -198.17 (-1.64%)
     
  • NASDAQ

    14,258.11
    +255.00 (+1.82%)
     
  • FTSE

    7,466.07
    -88.24 (-1.17%)
     
  • Dow Jones

    34,303.60
    +142.82 (+0.42%)
     
  • DAX

    15,318.95
    -205.32 (-1.32%)
     
  • Hang Seng

    23,550.08
    -256.92 (-1.08%)
     
  • NIKKEI 225

    26,717.34
    +547.04 (+2.09%)
     

Is Fulgent Genetics Undervalued?

·2-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • FLGT

Whether Fulgent is a value or a value trap depends on the short-term prospects for COVID-19 and the long-term prospects for its core sequencing business.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting